What are the recent financial highlights of PFIZER LTD?

PFIZER LTD recently reported a total revenue of ₹2,236.07 Cr and a net profit margin of 27.53%. These metrics reflect the company’s consistent financial performance.

What is the dividend yield of PFIZER LTD?

PFIZER LTD offers a dividend yield of 0.87%, with a dividend rate of ₹35.0 per share.

What are the key financial metrics of PFIZER LTD?

Key financial metrics include a trailing P/E ratio of 28.714518, forward P/E of 23.084827, book value of ₹819.814, price-to-book ratio of 4.713752, and a market capitalization of ₹176.79 billion.

What does PFIZER LTD do?

Pfizer Limited engages in manufacturing, marketing, trading, and export of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastro intestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers internal medicine and anti-infectives services to hospitals and nursing homes. It serves healthcare providers, government and private hospitals, and retail pharmacies. The company sells its products through a network of independent distributors. Pfizer Limited was incorporated in 1950 and is based in Mumbai, India.

Loading...

₹ 0 0.00%

Loading... BSE: Loding... NSE: Pfizer

About

Loading... ^[1]

Website BSE NSE

Market Cap ₹ 0 Cr.
Current Price ₹ 0
High / Low ₹ 0 / 0
Stock P/E
Dividend Yield 0 %
ROE 0 %
EPS 0
P/B Ratio 0
Net Profit Margin 0 %
Debt to Equity 0
ROCE 0 %
Interest Coverage 0 %

Stock News - Pfizer

Latest updates related to Pfizer

Sr No.	Title	Sentiment
1	GlaxoSmithKline seen as favourite to buy Pfizer's consumer healthcare unit after Reckitt Benckiser ends interest FirstWord Pharma	🔄
2	Pfizer wins bid to invalidate GSK's patents over RSV vaccine Reuters	🔄
3	Market Trading Guide: JK Cement, Pfizer among 4 stock recommendations for Wednesday The Economic Times	🔄
4	Pfizer stops production of Corex cough syrup Business Standard	🔄
5	SABCS: Pfizer’s IBRANCE combo improves PFS in breast cancer study Clinical Trials Arena	🔄
6	Pfizer, Minda Corp, Ajanta Pharma: Brokerage picks 5 stocks for short-term gain; note down targets Zee Business	🔄
7	Pfizer readies its next-generation COVID-19 antiviral Chemical & Engineering News	🔄
8	Pfizer’s Talzenna therapy accepted for use within NHS Scotland PharmaTimes	🔄
9	Rushed and risky: Dr Naomi Wolf challenges Pfizer's mRNA vaccine safety - India Today India Today	🔄
10	German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent Reuters	🔄

Peer Comparison

Macro Industry: Loading.. | Sector: Loading.. | Industry: Loading.. | Basic Industry: Loading..

Loading peers table...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Loading data...

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Loading Profit & Loss data...

Compounded Sales Growth
10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth
10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR
10 Years:
5 Years:
3 Years:
1 Year:

Return on Equity
10 Years:
5 Years:
3 Years:
Last Year:

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Shareholding Pattern

Numbers in percentages

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Loading...

Loading...

Stock News - Pfizer

Peer Comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Delivery Data

Insider Data

Technical Data

Static Application Security Testing

Documents

Announcements

Annual reports

Credit ratings

Concalls

Explore More Stocks